GlassScriptPhysician profile
John A Scolaro
NPI 1790983476
$1,001,704.37
in general payments reported to CMS, 2019-2025
24 companies · $153K in 2025
The $153K reported for 2025 was more than what 97% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112K · 2020: $71K · 2021: $121K · 2022: $176K · 2023: $184K · 2024: $184K · 2025: $153K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $308K · Travel and Lodging: $99K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Food and Beverage: $13K · Royalty Or License: $12K · Honoraria: $11K · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $307,727.76 |
| Travel and Lodging | $98,747.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $63,410.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $14,574.00 |
| Food and Beverage | $12,734.00 |
| Royalty Or License | $11,781.86 |
| Honoraria | $11,450.00 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $499,642.92 | 2019-2025 | Axsos, Gamma, Variax |
| Zimmer Biomet Holdings, INC. | $121,382.41 | 2019-2023 | Ncb, Affixus, Znn |
| Smith+Nephew, INC. | $116,523.73 | 2019-2025 | Evos, Trigen Intertan, Evos Mini |
| Synthes Gmbh | $67,404.44 | 2019-2025 | |
| Nuvasive Specialized Orthopedics, INC. | $67,011.39 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Globus Medical, INC. | $34,560.36 | 2019-2025 | Ankle Fracture System, Precice® Intramedullary Limb Lengthening System, Anthem |
| Orthofix Medical, INC. | $33,058.78 | 2019-2025 | Fitbone, Tl-Hex Truelok Hexapod System, Truelok |
| Illuminoss Medical, INC. | $18,172.62 | 2024-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Restor3d, INC. | $14,453.96 | 2021-2023 | |
| Tyber Medical, LLC | $10,627.30 | 2023 | Alps Plating System, Tyber Medical Anatomical Plating System |
| Sanara Medtech INC. | $8,290.06 | 2025 | |
| Medical Device Business Services, INC. | $7,538.07 | 2022 | |
| Biodynamik, INC | $1,500.00 | 2024 | |
| Kci USA, INC. | $975.01 | 2021 | |
| Depuy Synthes Sales INC. | $237.86 | 2022-2025 | Na |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| My01 INC. | $120.53 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Ziehm-Orthoscan, INC. | $56.45 | 2019 | |
| Osteocentric Technologies, INC. | $35.41 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Biedermann Motech, INC. | $31.66 | 2021 | |
| Becton, Dickinson and Company | $31.57 | 2025 | Surgiphor |
| Saxum Surgical, INC. | $23.00 | 2022 | |
| Nuvasive, INC. | $15.81 | 2020 | |
| Micromed INC | $11.03 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scolaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.